GlassScriptPhysician profile
Elena Novak
NPI 1962028985
$1,840.12
in general payments reported to CMS, 2019-2025
19 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $179 · 2023: $675 · 2024: $564 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.33 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $567.24 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $266.89 | 2021-2025 | Winlevi, Absorica Ld |
| Janssen Biotech, INC. | $259.37 | 2023 | Tremfya, Stelara, Remicade |
| Revance Therapeutics, INC. | $137.51 | 2024-2025 | Daxxify |
| Novartis Pharmaceuticals Corporation | $124.24 | 2022-2025 | |
| Biofrontera INC. | $121.88 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Pfizer INC. | $47.47 | 2023 | |
| Mimedx Group, INC. | $42.47 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $37.48 | 2024 | Ycanth |
| Dermavant Sciences, INC. | $35.18 | 2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $28.11 | 2023 | Libtayo |
| Organogenesis INC. | $25.66 | 2024 | Cygnus Dual |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.47 | 2023 | Spevigo |
| Arcutis Biotherapeutics, INC. | $23.13 | 2025 | Zoryve |
| Amgen INC. | $22.65 | 2023 | Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $20.98 | 2021 | |
| Strata Skin Sciences, INC. | $19.75 | 2025 | Xtrac |
| Galderma Laboratories, L.P. | $17.91 | 2021 | |
| Lilly USA, LLC | $17.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.